ClinicalTrials.gov
public full text
Public Domain
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
This is a Phase II randomized, double-blind, placebo-controlled trial of sildenafil in men and women with Scleroderma with mildly elevated pulmonary pressures (SSc-MEP) to determine whether sildenafil may be an effective treatment for SSc-MEP.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn#172436
- Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY#981920
- Premature Coronary Atherosclerosis in Scleroderma#1095665
- Sildenofil in Persistent Pulmonary Hypertension in Newborns#868596
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)#861106
Record · ID 1141032
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive